Abstract | AIMS: MATERIALS AND METHODS: RESULTS: No significant differences in plasma VEGF-C or VEGF-D levels were seen between patients subgrouped by clinicopathological variables. In particular, there were no differences in median plasma VEGF-C or VEGF-D level in patients with and without lymph-node involvement ( VEGF-C: 11.2 U/ml [range, 4.9-51.9] vs 9.9 U/ml [4.4-93.4 U/ml]; P = 0.90; VEGF-D: 335 pg/ml [113-1102] vs 316.5 pg/ml [0-1343]; P = 0.68). CONCLUSIONS: Circulating plasma levels of VEGF-C and VEGF-D do not allow pre-operative identification of lymph-node status in patients with colorectal cancer.
|
Authors | S E Duff, M Saunders, V McCredie, S Kumar, S T O'Dwyer, G C Jayson |
Journal | Clinical oncology (Royal College of Radiologists (Great Britain))
(Clin Oncol (R Coll Radiol))
Vol. 17
Issue 5
Pg. 367-71
(Aug 2005)
ISSN: 0936-6555 [Print] England |
PMID | 16097569
(Publication Type: Evaluation Study, Journal Article)
|
Chemical References |
- VEGFA protein, human
- VEGFC protein, human
- Vascular Endothelial Growth Factor A
- Vascular Endothelial Growth Factor C
- Vascular Endothelial Growth Factor D
- Vascular Endothelial Growth Factors
|
Topics |
- Adult
- Aged
- Cohort Studies
- Colorectal Neoplasms
(blood, pathology)
- Female
- Humans
- Lymphatic Metastasis
(diagnosis)
- Male
- Middle Aged
- Vascular Endothelial Growth Factor A
(blood)
- Vascular Endothelial Growth Factor C
(blood)
- Vascular Endothelial Growth Factor D
(blood)
- Vascular Endothelial Growth Factors
(blood)
|